GB1297080A - - Google Patents

Info

Publication number
GB1297080A
GB1297080A GB1297080DA GB1297080A GB 1297080 A GB1297080 A GB 1297080A GB 1297080D A GB1297080D A GB 1297080DA GB 1297080 A GB1297080 A GB 1297080A
Authority
GB
United Kingdom
Prior art keywords
carbamyl
salts
aspartate
neutral
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GB1838870 priority Critical
Publication of GB1297080A publication Critical patent/GB1297080A/en
Application status is Expired legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulfur or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Abstract

1297080 Salts of pyridoxine, heptaminol and diethylaminoethyltheophylline SOC GENERALE DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES 19 April 1971 [17 April 1970] 183S8/70 Headings C2C and C2V The invention comprises salts formed from pyridoxine, heptaminol and diethylamincethyltheophylline with N-carbamyl-glutamic acid and N-carbamyl-dl- and l-aspartic acid. The salts are formed by reaction between the bases and the acids in solution in water, an alcohol or dimethylsulphoxide. In examples the following salts are prepared:-pyridoxide N-carbamyldl-aspartate (acid and neutral salts), pyridoxine N-carbamyl-l-aspartate (acid and neutral salts), heptaminol N-carbamyl-dl-aspartate (neutral salt), dicthylaminoethyltheophylline N-carbamyl-dl-aspartate (neutral salt), diethylaminoethyltheophylline N - carbamyl - l - aspartate (neutral salt), pyridoxine N-carbamyl-l-glutamate (acid and neutral salts), heptaminol N- carbamyl-l-glutamate (neutral salt) and diethylaminoethylthiophylline N - carbamyl - l - glutamate (neutral salt). Pharmaceutical compositions comprise the above-mentioned salts together with suitable carriers, for the treatment of cardiac, respiratory, neurological and muscular disorders.
GB1297080D 1970-04-17 1970-04-17 Expired GB1297080A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1838870 1970-04-17

Publications (1)

Publication Number Publication Date
GB1297080A true GB1297080A (en) 1972-11-22

Family

ID=10111604

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1297080D Expired GB1297080A (en) 1970-04-17 1970-04-17

Country Status (3)

Country Link
DE (1) DE2118109A1 (en)
FR (1) FR2086138B1 (en)
GB (1) GB1297080A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5805M (en) * 1966-07-25 1968-02-19
FR5862M (en) * 1966-07-26 1968-03-11
GB1182815A (en) * 1967-06-13 1970-03-04 Prodotti Antibiotici Spa New Salts of N-Carbamyl-Glutamic Acid and of N-Carbamyl-Aspartic Acid.

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR2086138A1 (en) 1971-12-31
DE2118109A1 (en) 1971-12-02
FR2086138B1 (en) 1974-09-27

Similar Documents

Publication Publication Date Title
DE1958123B2 (en) A process for the preparation of 1-aminoalkane-1,1-diphosphonic acids or salts thereof
RO62643A (en) Process for the preparation of dissymetric esters of 1,4-dihydropyridin-3,5-dicarboxylic acid
GB1291631A (en) Triazolobenzodiazepine derivatives
AT324341B (en) Processes for production of new pyridine derivatives and their acid addition salts
AT302276B (en) A process for the preparation of novel α-tert. Butylaminopropiophenonen and acid addition salts
GB2056492B (en) Electrolytic production of trichloropicolinic acids and/or 3,6-dichloropicolinic acid
DE2237765A1 (en) New amino derivatives of pyrazolo (3,4-b) pyridine-5-carboxylic acids with esters thereof and salts, processes for their preparation and their use
DK155328C (en) Process for the preparation of 1-substituted 1,3,4,9-tetrahydropyrano (or thiopyrano) - (3,4-b) indole-1-alkanoic acids, their salts or esters
BE791653A (en) Method of preparation of the acid electrolytic
IL49315A (en) Process for the production of an enzymatically active product insoluble in aqueous medium
GB1393503A (en) Aminoadamantanes and their use as medicaments for affecting the central nervous system
SU504480A3 (en) Method for producing amides of (1 (-phenylalkyl) -piperidyl-4 -) - (-pyridyl) -carboxylic acid or their salts
AT323181B (en) A process for the preparation of novel pyrrolo (3,4-b) pyrazine derivatives as well as acid addition salts of the
SE8605063D0 (en) Derivatives of cyclohexane
AT318619B (en) A process for the preparation of novel thieno [3,2-d] pyrimidines and their acid addition salts
IN139119B (en) Process for the preparation of 8-alkyl-5-oxo-5,8-dihydro-pyrido(2,3-d)pyrimidine-6-carboxylic acid
AT298485B (en) A process for the preparation of novel imidazoline derivatives and their acid addition salts
CA1032081A (en) Method of treatment of calcium disorders using cyclohexane-hexacarboxylic acid
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
JPS54160740A (en) Anti-fibrotic agent
BE790026R (en) Process for the preparation of derivatives body of the acid
SE7504336A (en)
BE763091A (en) Process for preparing naphthalene-monocarboxylic acid or naphthalene-dicarboxylic acid
CA1010041A (en) Process for the production of basically substituted benzylphthalazone derivatives and acid addition salts thereof
SU578854A3 (en) Method of preparing substituted diphenylpropionic acid or its derivatives or salts

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee